Key statistics
On Saturday, Resmed Inc (R1MD34:SAO) closed at 329.59, 8.87% above its 52-week low of 302.75, set on Apr 08, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 330.20 |
|---|---|
| High | 330.20 |
| Low | 329.59 |
| Bid | 327.43 |
| Offer | 340.77 |
| Previous close | 328.50 |
| Average volume | 51.00 |
|---|---|
| Shares outstanding | -- |
| Free float | -- |
| P/E (TTM) | -- |
| Market cap | -- |
| EPS (TTM) | -- |
| Annual div (ADY) | 2.20 BRL |
|---|---|
| Annual div yield (ADY) | 0.67% |
| Div ex-date | Feb 11 2026 |
| Div pay-date | Mar 20 2026 |
Data delayed at least 15 minutes, as of Feb 14 2026 00:45 GMT.
More ▼
Announcements
- Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026
- Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026
- Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
- Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy
- Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026
- Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025
- Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025
- Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
- Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds
- Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs
More ▼
